Linda J. Pike, Ph.D.

Biochemistry and Molecular Biophysics

Biochemistry, Biophysics, and Structural Biology Program
Molecular Cell Biology Program

  • 314-362-9502

  • 314-362-9501

  • 314-362-7183

  • 8231

  • 206 McDonnell Sciences Bldg



  • signal transduction, cell signaling, cancer, EGF receptor

  • EGF receptor-mediated cell signaling and the control of cell growth

Research Abstract:

The EGF receptor is a ubiquitously expressed cell surface receptor tyrosine kinase. Stimulation of cells with EGF leads to increases in metabolic activity and ultimately in cell proliferation. The EGF receptor and its homologous ErbB family members are over-expressed in many human tumors and several clinically useful drugs are directed against these proteins. My laboratory is interested in the the regulation of cell signaling via the EGF receptor and ErbB family members. We are particularly interested in the early steps that follow the binding of ligand and in understanding how the structure of the receptor enables transduction of the ligand binding signal through the membrane.

In the membrane, the EGF receptor is thought to exist as a dimer, but upon binding ligand, the receptor dimerizes and its tyrosine kinase is activated. Using ligand binding analyses, we have shown that the EGF receptor exhibits negative cooperativity between binding sites in the active dimer and we are currently doing a mutational analysis to define the structural aspects of the EGF receptor that underlie this allosteric phenomenon. More recently, we have uncovered evidence for higher order oligomerization of the receptor, that appears to be susceptible to alteration by therapeutic inhibitors of the EGF receptor kinase. We are investigating how these higher order oligomers modulate EGF receptor-mediated signaling and how this effects the efficacy of molecularly targeted therapies.

We previously developed a split luciferase enzyme complementation system that allows us to image EGF receptor dimerization in real time in live cells. We have now extended this system to allow us to measure the association of the EGF receptor with important downstream signaling molecules to allow us to understand how the binding of these proteins to the receptor affects the signaling capacity of the receptor. We have characterized the binding of eight different downstream signaling proteins to the EGF receptor stimulated by seven different EGF receptor ligands. Currently, we are using principal component analysis, clustering and network analysis to identify differences among the growth factors in the way they stimulate different pathways in the network.

X-ray crystallographic structures exist for both the extracellular domain of the EGF receptor and the intracellular kinase domain. However, the structure of the C-terminal tail, to which all the signaling proteins bind, is unknown. The reason for this is that this ~200 amino acid segment is intrinsically disordered. Using FPOP footprinting and MD simulations, we are attempting to generate structural models that will tell us how the different proteins bind to the EGF receptor tail and how many might be able to bind to a single receptor. We are also doing a mutational analysis of the tail to determine whether it is just the intrinsic disorder that is important for the signaling function of the tale or whether there are auxiliary sequences that contribute to the regulation of protein-protein interactions.

Selected Publications:

Macdonald-Obermann, J.L. and Pike, L.J. (2014) Different EGF Receptor Ligands Show Distinct Kinetics and Biased or Partial Agonism for Homodimer and Heterodimer Formation, J. Biol. Chem. 289: 26178-26188.

Macdonald-Obermann, J.L., Adak, D., Landgraf, R., Piwnica-Worms, D. and Pike, L.J. (2013) Dynamic Analysis of the Epidermal Growth Factor (EGF) Receptor-ErbB2-ErbB3 Protein Network by Luciferase Fragment Complementation Imaging. J. Biol. Chem. 288: 30773-30784.

Li, Y., Macdonald-Obermann, J.L., Westfall, C., Piwnica-Worms, D., and Pike, L.J. (2012) Quantitation of the Effect of ErbB2 on EGF Receptor Binding and Dimerization. J. Biol. Chem. 287: 31116-31125

Macdonald-Obermann J, Yang KS, Piwnica-Worms D and Pike LJ. Mechanics of EGF Receptor/ErbB2 Kinase Activation Revealed by Luciferase Fragment Complementation Imaging. Proc. Natl. Acad. Sci. U.S.A. 2012 109:137-142.

Adak S, Yang KS, Macdonald-Obermann J and Pike LJ. The Membrane Proximal Region of the Intracellular Domain of the EGF Receptor is Responsible for Negative Cooperativity in Ligand Binding. J. Biol. Chem. 2011 286: 45146-45155.

Yang KS, Macdonald-Oberman JL, Piwnica-Worms D and Pike LJ. Asp-960/Glu-961 control the movement of the C-terminal tail of the EGF receptor to regulate asymmetric dimer formation. J. Biol. Chem.2010 285: 24014-24022.

Yang KS, Illagan M XG, Piwnica-Worms D and Pike LJ. Luciferase Fragment Complementation Imaging of Conformational Changes in the EGF receptor. J. Biol. Chem. 2009 284:7474-7482.

Macdonald-Obermann JL and Pike LJ. The Intracellular Juxtamembrane Domain of the EGF Receptor is Responsible for the Allosteric Regulation of EGF Binding. J. Biol. Chem. 2009 284:13,570-13,576.

Last Updated: 8/28/2015 4:51:30 PM

Back To Top

Follow us: